KKR & Co. arrives at its August 4 Q3 earnings date in a materially different position than it faced heading into Q2 — the stock gained 2.1% on the July 30 print, has added another 2% this week to $101.43, and analysts moved quickly to raise targets rather than trim them.
The post-Q2 repricing has shifted the analyst debate. RBC Capital and Barclays both raised targets on July 31 — RBC to $134, Barclays to $135 — maintaining positive ratings after the beat. That follows Morgan Stanley's Michael Cyprys trimming his target to $147 earlier in the month while holding Overweight, a ceiling that still implies meaningful upside. The consensus mean target now sits at $124.78, around 23% above the current price. Bulls point to KKR's $723 billion in managed assets, its diversified model across private equity, credit, infrastructure and insurance, and the company's employee ownership program as structural advantages. Bears remain focused on management's acknowledged difficulty hitting its $7/share ANI target for 2026, macro volatility clouding exit timing, and the Strategic Holdings segment's limited near-term contribution to valuation. The forward EPS growth trajectory ranks in the 79th percentile across the ORTEX universe — the growth story is intact, but the pace is the argument.
Positioning going into the August print is notably lighter on defensiveness than it was pre-Q2. Short interest has fallen sharply — down 15% over the past week and nearly 18% from mid-July highs, to just 1.5% of the float. The lending market remains completely unencumbered: borrow availability is essentially unlimited, cost to borrow barely clears 0.47%, and utilization is negligible. The options market still carries a structural put bias — the put/call ratio is running at 1.80, well above its 52-week low of 0.98 — but that reading is slightly below its 20-day average of 1.83, suggesting the persistent defensiveness that defined the pre-Q2 setup has eased modestly rather than intensified. Peers moved broadly higher on the week, with up 10%, up 6%, and up nearly 3%, pointing to sector-wide strength rather than a KKR-specific recovery story.
The insider buying cluster from February — both co-CEOs Joseph Bae and Scott Nuttall purchasing stock at prices between $87 and $103 — now looks well-timed with the stock back at those levels. That data is now more than five months old, but the pattern of C-suite conviction at current price levels remains part of the stock's narrative backdrop.
The August 4 print will test whether KKR's Q2 momentum — the beat that prompted the target upgrades — reflects a durable inflection in fee-earning AUM and ANI trajectory, or a one-quarter recovery in an environment where macro conditions can still delay realizations and compress the 2026 earnings guide.
See the live data behind this article on ORTEX.
Open KKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
KKR & Co. enters its July 30 earnings print in an unusual position: the stock is down 1.6% on the week and has shed roughly a quarter of its value year-to-date, yet the analyst community remains firmly in the bull camp…
KKR heads into its August 4 earnings report with an unusual ownership dynamic: its own Co-CEOs and directors bought shares aggressively during February and March's sell-off, yet the stock at $91.78 remains below every…
